An Extended Access Program for Bardoxolone Methyl in Patients With CKD (EAGLE)

NCT03749447 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

270

Enrollment

INDUSTRY

Sponsor class

Stopped Discontinuation of all bardoxolone chronic kidney disease programs

Conditions

Chronic Kidney Diseases
Alport Syndrome
Autosomal Dominant Polycystic Kidney

Interventions

DRUG: Bardoxolone methyl

Sponsor

Biogen